IN INO $1.27 ▲ +0.79% Should I Buy Inovio Pharmaceuticals (INO)? Finance YouTuber Analysis
VERDICT: WATCH 0/100
Get weekly updates on this stock
“The YouTuber suggests Inovio Pharmaceuticals as a short squeeze play, highlighting its pipeline of 11 potential drugs, many in Phase 2 or later…”
Financials
Reported figures · last 5 yearsCall record — INO
1 CALLS · 0 BUY / 0 SELL / 1 WATCHCreate a free account to see every call — who, when, at what price.
Each call is dated, linked to the source video, and graded. Free accounts see the full record.
FAQ
Should I buy Inovio Pharmaceuticals?
1 finance YouTubers analysed Inovio Pharmaceuticals with qualified reasoning — consensus: Watch, average analysis quality 60/100. This is not financial advice; review the individual analyses and sources above.
Are finance YouTubers bullish or bearish on Inovio Pharmaceuticals?
Among the channels covering Inovio Pharmaceuticals, 0 are buying and 0 are selling or avoiding — overall Watch.
How do you decide what to include for Inovio Pharmaceuticals?
Only qualified analyses count: a clear buy/sell stance on Inovio Pharmaceuticals with real reasoning (valuation, fundamentals, a catalyst or a chart setup). Passing mentions are excluded.